|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0085415,
umls-concept:C0175659,
umls-concept:C0205210,
umls-concept:C0205251,
umls-concept:C0205372,
umls-concept:C0206065,
umls-concept:C0222045,
umls-concept:C0349674,
umls-concept:C0449450,
umls-concept:C0449820,
umls-concept:C0597198,
umls-concept:C1621958,
umls-concept:C1706852,
umls-concept:C1947933,
umls-concept:C2607850
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-8-2
|
|
pubmed:abstractText |
The object of this study was to determine the benefit of surgery, radiation, and chemotherapy for patients with glioblastoma multiforme (GBM) and a low Karnofsky Performance Scale (KPS) score.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1933-0693
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
220-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21548745-Adult,
pubmed-meshheading:21548745-Aged,
pubmed-meshheading:21548745-Aged, 80 and over,
pubmed-meshheading:21548745-Brain Neoplasms,
pubmed-meshheading:21548745-Combined Modality Therapy,
pubmed-meshheading:21548745-Female,
pubmed-meshheading:21548745-Follow-Up Studies,
pubmed-meshheading:21548745-Glioblastoma,
pubmed-meshheading:21548745-Humans,
pubmed-meshheading:21548745-Karnofsky Performance Status,
pubmed-meshheading:21548745-Male,
pubmed-meshheading:21548745-Middle Aged,
pubmed-meshheading:21548745-Predictive Value of Tests,
pubmed-meshheading:21548745-Prognosis,
pubmed-meshheading:21548745-Retrospective Studies,
pubmed-meshheading:21548745-Survival Analysis,
pubmed-meshheading:21548745-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
|
|
pubmed:affiliation |
Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan, USA.
|
|
pubmed:publicationType |
Journal Article
|
